In a biological sense, agalactosis historically represented a fatal threat to the newborn. In modern medicine, the physical threat is mitigated by high-quality infant formulas. However, the psychological impact on the mother can be profound. Many women experience a sense of "biological failure" or grief, necessitating empathetic clinical support and a focus on alternative bonding methods.
Agalactosis remains a rare but definitive reminder of the complexity of the reproductive system. Whether caused by acute trauma, such as pituitary damage, or underlying systemic illness, it requires a multifaceted response that prioritizes infant nutrition while addressing the underlying hormonal or physical health of the mother.
In humans, one of the most noted causes is , where severe postpartum hemorrhage leads to necrosis of the pituitary gland. Because the pituitary produces prolactin, its damage can permanently inhibit milk production. Other causes include severe primary mammary glandular hypoplasia (insufficient breast tissue) or rare genetic mutations affecting hormone receptors. Diagnostic Distinctions
The production of milk (lactogenesis) is a complex hormonal symphony. It primarily depends on the drop in progesterone following the delivery of the placenta and the subsequent rise in , the hormone responsible for milk synthesis. Agalactosis typically stems from a disruption in this endocrine balance.
It is crucial to distinguish true agalactosis from (insufficient milk supply). Most breastfeeding difficulties are related to "latch" issues, infrequent feeding, or delayed lactogenesis II (where milk "comes in" later than the typical 72-hour window). Agalactosis is absolute; regardless of stimulation or demand, the mammary glands remain inactive. Impact and Management